nodes	percent_of_prediction	percent_of_DWPC	metapath
Mestranol—ESR1—atherosclerosis	0.666	1	CbGaD
Mestranol—CYP2C9—Rosuvastatin—atherosclerosis	0.0778	0.267	CbGbCtD
Mestranol—CYP2C9—Simvastatin—atherosclerosis	0.0724	0.248	CbGbCtD
Mestranol—CYP2C9—Lovastatin—atherosclerosis	0.0708	0.243	CbGbCtD
Mestranol—CYP2C9—Pravastatin—atherosclerosis	0.0708	0.243	CbGbCtD
Mestranol—Estriol—ESR2—atherosclerosis	0.000654	0.0835	CrCbGaD
Mestranol—Danazol—CCL2—atherosclerosis	0.000618	0.079	CrCbGaD
Mestranol—Quinestrol—ESR1—atherosclerosis	0.000609	0.0778	CrCbGaD
Mestranol—Estramustine—ESR2—atherosclerosis	0.000608	0.0776	CrCbGaD
Mestranol—Estropipate—ESR2—atherosclerosis	0.0005	0.0638	CrCbGaD
Mestranol—Desogestrel—ESR1—atherosclerosis	0.000456	0.0582	CrCbGaD
Mestranol—Estriol—ESR1—atherosclerosis	0.000403	0.0514	CrCbGaD
Mestranol—Estramustine—ESR1—atherosclerosis	0.000374	0.0478	CrCbGaD
Mestranol—Etonogestrel—ESR1—atherosclerosis	0.000369	0.0471	CrCbGaD
Mestranol—Ethinyl Estradiol—ESR2—atherosclerosis	0.000357	0.0456	CrCbGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—CD36—atherosclerosis	0.000319	0.00942	CbGpPWpGaD
Mestranol—Conjugated Estrogens—ESR2—atherosclerosis	0.000312	0.0398	CrCbGaD
Mestranol—Estrone—ESR2—atherosclerosis	0.000311	0.0397	CrCbGaD
Mestranol—ESR1—ATF-2 transcription factor network—SOCS3—atherosclerosis	0.000308	0.00912	CbGpPWpGaD
Mestranol—Estropipate—ESR1—atherosclerosis	0.000308	0.0393	CrCbGaD
Mestranol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.000306	0.00904	CbGpPWpGaD
Mestranol—CYP2C9—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000302	0.00892	CbGpPWpGaD
Mestranol—ESR1—Validated nuclear estrogen receptor alpha network—SOD1—atherosclerosis	0.000292	0.00865	CbGpPWpGaD
Mestranol—ESR1—Estrogen signaling pathway—NFKB1—atherosclerosis	0.000291	0.00861	CbGpPWpGaD
Mestranol—ESR1—Nuclear Receptors—PPARG—atherosclerosis	0.000285	0.00844	CbGpPWpGaD
Mestranol—CYP2C9—Arachidonic acid metabolism—ALOX5—atherosclerosis	0.000285	0.00843	CbGpPWpGaD
Mestranol—ESR1—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.000273	0.00807	CbGpPWpGaD
Mestranol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000269	0.00795	CbGpPWpGaD
Mestranol—CYP2C9—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000268	0.00793	CbGpPWpGaD
Mestranol—Levonorgestrel—ESR1—atherosclerosis	0.000261	0.0333	CrCbGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—IGF1—atherosclerosis	0.000255	0.00753	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—SOCS3—atherosclerosis	0.000254	0.00752	CbGpPWpGaD
Mestranol—ESR1—FOXA1 transcription factor network—INS—atherosclerosis	0.000249	0.00736	CbGpPWpGaD
Mestranol—CYP2C9—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000248	0.00733	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—EDN1—atherosclerosis	0.000247	0.0073	CbGpPWpGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—MMP2—atherosclerosis	0.000246	0.00729	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—AHR—atherosclerosis	0.000244	0.00723	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—IL10—atherosclerosis	0.000244	0.00722	CbGpPWpGaD
Mestranol—ESR1—FOXM1 transcription factor network—MMP2—atherosclerosis	0.000242	0.00715	CbGpPWpGaD
Mestranol—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—atherosclerosis	0.00024	0.00709	CbGpPWpGaD
Mestranol—Danazol—ESR1—atherosclerosis	0.000238	0.0304	CrCbGaD
Mestranol—Estradiol—ESR2—atherosclerosis	0.000236	0.0301	CrCbGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—NOS3—atherosclerosis	0.000231	0.00683	CbGpPWpGaD
Mestranol—ESR1—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.000225	0.00667	CbGpPWpGaD
Mestranol—Ethinyl Estradiol—ESR1—atherosclerosis	0.00022	0.0281	CrCbGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—atherosclerosis	0.000217	0.00642	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—NOS2—atherosclerosis	0.000215	0.00635	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—MMP1—atherosclerosis	0.000208	0.00614	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—AGT—atherosclerosis	0.000205	0.00606	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—INS—atherosclerosis	0.000197	0.00582	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—atherosclerosis	0.000193	0.0057	CbGpPWpGaD
Mestranol—Conjugated Estrogens—ESR1—atherosclerosis	0.000192	0.0245	CrCbGaD
Mestranol—Estrone—ESR1—atherosclerosis	0.000192	0.0245	CrCbGaD
Mestranol—ESR1—Leptin signaling pathway—LEP—atherosclerosis	0.00019	0.00562	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.000187	0.00553	CbGpPWpGaD
Mestranol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000186	0.00551	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—HMGCR—atherosclerosis	0.000185	0.00548	CbGpPWpGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—MMP9—atherosclerosis	0.000185	0.00548	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—MMP2—atherosclerosis	0.000184	0.00545	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—CCL2—atherosclerosis	0.000169	0.00499	CbGpPWpGaD
Mestranol—ESR1—Estrogen signaling pathway—AKT1—atherosclerosis	0.000169	0.00498	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	0.000167	0.00494	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—IFNG—atherosclerosis	0.000165	0.00487	CbGpPWpGaD
Mestranol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000154	0.00456	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—CXCL8—atherosclerosis	0.000153	0.00453	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	0.000152	0.00449	CbGpPWpGaD
Mestranol—CYP2C9—Arachidonic acid metabolism—GPX1—atherosclerosis	0.000151	0.00447	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—IFNG—atherosclerosis	0.000147	0.00435	CbGpPWpGaD
Mestranol—Estradiol—ESR1—atherosclerosis	0.000145	0.0185	CrCbGaD
Mestranol—ESR1—AP-1 transcription factor network—IFNG—atherosclerosis	0.000144	0.00425	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—NOS3—atherosclerosis	0.000142	0.00421	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—CYP7A1—atherosclerosis	0.000142	0.00421	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000142	0.00419	CbGpPWpGaD
Mestranol—CYP2C9—Metapathway biotransformation—CYP7A1—atherosclerosis	0.00014	0.00415	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.00014	0.00415	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—SIRT1—atherosclerosis	0.000138	0.00407	CbGpPWpGaD
Mestranol—Estropipate—ALB—atherosclerosis	0.000137	0.0175	CrCbGaD
Mestranol—ESR1—ATF-2 transcription factor network—MAPK8—atherosclerosis	0.000135	0.00398	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—CXCL8—atherosclerosis	0.000133	0.00395	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—CYP27A1—atherosclerosis	0.000132	0.00389	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	0.00013	0.00384	CbGpPWpGaD
Mestranol—CYP2C9—Metapathway biotransformation—CYP27A1—atherosclerosis	0.00013	0.00384	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—NFKB1—atherosclerosis	0.000122	0.00362	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—IL1B—atherosclerosis	0.000121	0.00358	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—MMP9—atherosclerosis	0.000121	0.00357	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—MAPK3—atherosclerosis	0.000118	0.00348	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000114	0.00337	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—NFKB1—atherosclerosis	0.000113	0.00334	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—PDGFB—atherosclerosis	0.000113	0.00334	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—MMP1—atherosclerosis	0.000112	0.00332	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—MAPK8—atherosclerosis	0.000111	0.00329	CbGpPWpGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—AKT1—atherosclerosis	0.000106	0.00314	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—MAPK3—atherosclerosis	0.000105	0.0031	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—TGFB1—atherosclerosis	0.000102	0.00301	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000102	0.00301	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—STAT3—atherosclerosis	0.000102	0.003	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—TGFB1—atherosclerosis	9.95e-05	0.00294	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—MAPK3—atherosclerosis	9.7e-05	0.00287	CbGpPWpGaD
Mestranol—Norethindrone—ALB—atherosclerosis	9.42e-05	0.012	CrCbGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	9.36e-05	0.00277	CbGpPWpGaD
Mestranol—Methyltestosterone—ALB—atherosclerosis	8.94e-05	0.0114	CrCbGaD
Mestranol—CYP2C9—Arachidonic acid metabolism—PTGS2—atherosclerosis	8.9e-05	0.00263	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	8.8e-05	0.0026	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—IL6—atherosclerosis	8.6e-05	0.00254	CbGpPWpGaD
Mestranol—Estrone—ALB—atherosclerosis	8.53e-05	0.0109	CrCbGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	7.63e-05	0.00226	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	7.63e-05	0.00226	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—IL6—atherosclerosis	7.5e-05	0.00222	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	7.43e-05	0.0022	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—PARP1—atherosclerosis	7.43e-05	0.0022	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—AKT1—atherosclerosis	7.08e-05	0.00209	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—ESR2—atherosclerosis	7.04e-05	0.00208	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—AKT1—atherosclerosis	6.55e-05	0.00194	CbGpPWpGaD
Mestranol—Estradiol—ALB—atherosclerosis	6.47e-05	0.00826	CrCbGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—NFKB1—atherosclerosis	6.46e-05	0.00191	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	6.17e-05	0.00182	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	6.15e-05	0.00182	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	6.03e-05	0.00178	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—GSTM1—atherosclerosis	5.88e-05	0.00174	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—VEGFA—atherosclerosis	5.86e-05	0.00173	CbGpPWpGaD
Mestranol—CYP2C9—Metapathway biotransformation—GSTM1—atherosclerosis	5.8e-05	0.00171	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	5.67e-05	0.00168	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	5.67e-05	0.00168	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	5.57e-05	0.00165	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—MAPK3—atherosclerosis	5.51e-05	0.00163	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	5.47e-05	0.00162	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	5.35e-05	0.00158	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—HRH1—atherosclerosis	5.34e-05	0.00158	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	5.26e-05	0.00156	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	5.05e-05	0.00149	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	4.86e-05	0.00144	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	4.79e-05	0.00142	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	4.79e-05	0.00142	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	4.79e-05	0.00142	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	4.79e-05	0.00142	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	4.73e-05	0.0014	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—PPARA—atherosclerosis	4.71e-05	0.00139	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	4.59e-05	0.00136	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	4.57e-05	0.00135	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	4.46e-05	0.00132	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	4.38e-05	0.0013	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	4.22e-05	0.00125	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—APOA4—atherosclerosis	4.19e-05	0.00124	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	4.17e-05	0.00123	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	4.16e-05	0.00123	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	4.07e-05	0.0012	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—IL6—atherosclerosis	4.03e-05	0.00119	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—HSPA1B—atherosclerosis	4.01e-05	0.00119	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PLTP—atherosclerosis	3.92e-05	0.00116	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—PPARG—atherosclerosis	3.89e-05	0.00115	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CCL4—atherosclerosis	3.86e-05	0.00114	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	3.74e-05	0.00111	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—AKT1—atherosclerosis	3.72e-05	0.0011	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	3.63e-05	0.00107	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—APOA2—atherosclerosis	3.61e-05	0.00107	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	3.61e-05	0.00107	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	3.59e-05	0.00106	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—PARP1—atherosclerosis	3.58e-05	0.00106	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—SERPINE1—atherosclerosis	3.51e-05	0.00104	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	3.5e-05	0.00104	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—UTS2—atherosclerosis	3.44e-05	0.00102	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ABCG8—atherosclerosis	3.4e-05	0.001	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—LTA4H—atherosclerosis	3.4e-05	0.001	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—ESR2—atherosclerosis	3.39e-05	0.001	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	3.35e-05	0.000992	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CX3CR1—atherosclerosis	3.3e-05	0.000976	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CASR—atherosclerosis	3.3e-05	0.000976	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CX3CL1—atherosclerosis	3.24e-05	0.000957	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	3.17e-05	0.000937	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.1e-05	0.000916	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CNR2—atherosclerosis	3.07e-05	0.000908	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.82e-05	0.000835	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—VWF—atherosclerosis	2.74e-05	0.000809	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—SIRT1—atherosclerosis	2.73e-05	0.000807	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—APOC3—atherosclerosis	2.72e-05	0.000804	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—LDLR—atherosclerosis	2.7e-05	0.000799	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ABCG1—atherosclerosis	2.69e-05	0.000794	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CCL3—atherosclerosis	2.64e-05	0.000781	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—NCF1—atherosclerosis	2.53e-05	0.000747	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—LCAT—atherosclerosis	2.52e-05	0.000747	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—FABP4—atherosclerosis	2.52e-05	0.000747	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—APOA4—atherosclerosis	2.48e-05	0.000733	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP7A1—atherosclerosis	2.43e-05	0.00072	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—EDNRA—atherosclerosis	2.39e-05	0.000706	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CCR2—atherosclerosis	2.39e-05	0.000706	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CYBA—atherosclerosis	2.38e-05	0.000703	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PLAT—atherosclerosis	2.33e-05	0.000688	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—GHRL—atherosclerosis	2.33e-05	0.000688	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PARP1—atherosclerosis	2.33e-05	0.000688	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.32e-05	0.000686	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—PPARA—atherosclerosis	2.27e-05	0.000671	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP27A1—atherosclerosis	2.25e-05	0.000666	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.22e-05	0.000655	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.16e-05	0.000639	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	2.13e-05	0.000631	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—APOA2—atherosclerosis	2.13e-05	0.000631	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	2.13e-05	0.000631	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ALOX15—atherosclerosis	2.13e-05	0.000631	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ABCG5—atherosclerosis	2.11e-05	0.000623	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.11e-05	0.000623	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—KNG1—atherosclerosis	2.04e-05	0.000604	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—LPA—atherosclerosis	2.04e-05	0.000602	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—AGTR1—atherosclerosis	2.03e-05	0.0006	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PLG—atherosclerosis	1.98e-05	0.000585	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—BGN—atherosclerosis	1.97e-05	0.000583	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.96e-05	0.000579	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—APOA5—atherosclerosis	1.95e-05	0.000577	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.9e-05	0.000561	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.88e-05	0.000556	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—PPARG—atherosclerosis	1.87e-05	0.000554	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—SOCS3—atherosclerosis	1.87e-05	0.000554	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.86e-05	0.000549	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.84e-05	0.000544	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.84e-05	0.000543	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.81e-05	0.000537	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—MMP3—atherosclerosis	1.81e-05	0.000535	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—IGF2—atherosclerosis	1.8e-05	0.000533	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—APOB—atherosclerosis	1.75e-05	0.000517	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—EDN1—atherosclerosis	1.72e-05	0.000509	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CCL5—atherosclerosis	1.71e-05	0.000505	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—SERPINE1—atherosclerosis	1.69e-05	0.000499	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.68e-05	0.000496	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—LPL—atherosclerosis	1.67e-05	0.000494	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.63e-05	0.000481	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PRKCG—atherosclerosis	1.62e-05	0.00048	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.62e-05	0.000478	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—LIPC—atherosclerosis	1.62e-05	0.000478	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—APOC3—atherosclerosis	1.61e-05	0.000475	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—LDLR—atherosclerosis	1.6e-05	0.000472	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—SPP1—atherosclerosis	1.58e-05	0.000468	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CETP—atherosclerosis	1.56e-05	0.000461	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.49e-05	0.000442	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PDGFB—atherosclerosis	1.46e-05	0.000433	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.45e-05	0.00043	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—AGT—atherosclerosis	1.43e-05	0.000422	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.41e-05	0.000417	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—LEP—atherosclerosis	1.4e-05	0.000414	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—APOE—atherosclerosis	1.4e-05	0.000414	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CAV1—atherosclerosis	1.39e-05	0.00041	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—APOA1—atherosclerosis	1.38e-05	0.000409	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—F2—atherosclerosis	1.32e-05	0.00039	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.27e-05	0.000376	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PIK3CG—atherosclerosis	1.26e-05	0.000373	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.26e-05	0.000372	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—INS—atherosclerosis	1.2e-05	0.000354	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CCL2—atherosclerosis	1.18e-05	0.000348	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—IGF1—atherosclerosis	1.16e-05	0.000342	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—MAPK3—atherosclerosis	1.1e-05	0.000325	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—SERPINE1—atherosclerosis	1.1e-05	0.000325	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.08e-05	0.000319	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—NOS3—atherosclerosis	1.05e-05	0.00031	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—APOB—atherosclerosis	1.03e-05	0.000306	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.01e-05	0.000297	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—LPL—atherosclerosis	9.87e-06	0.000292	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GPX1—atherosclerosis	9.63e-06	0.000285	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CD36—atherosclerosis	9.37e-06	0.000277	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CXCL8—atherosclerosis	9.3e-06	0.000275	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—MTHFR—atherosclerosis	8.88e-06	0.000263	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PPARA—atherosclerosis	8.72e-06	0.000258	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—AGT—atherosclerosis	8.44e-06	0.00025	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—MMP9—atherosclerosis	8.41e-06	0.000249	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—NFKB1—atherosclerosis	8.32e-06	0.000246	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—APOE—atherosclerosis	8.27e-06	0.000245	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CAV1—atherosclerosis	8.19e-06	0.000242	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—MAPK8—atherosclerosis	8.18e-06	0.000242	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—APOA1—atherosclerosis	8.18e-06	0.000242	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—VEGFA—atherosclerosis	7.55e-06	0.000223	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—STAT3—atherosclerosis	7.48e-06	0.000221	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PIK3CG—atherosclerosis	7.46e-06	0.000221	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—AKT1—atherosclerosis	7.41e-06	0.000219	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PPARG—atherosclerosis	7.2e-06	0.000213	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—MAPK3—atherosclerosis	7.14e-06	0.000211	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—INS—atherosclerosis	7.07e-06	0.000209	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—TGFB1—atherosclerosis	6.93e-06	0.000205	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ALB—atherosclerosis	6.48e-06	0.000192	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—NOS3—atherosclerosis	6.2e-06	0.000183	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PTGS2—atherosclerosis	5.67e-06	0.000168	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—IL6—atherosclerosis	5.22e-06	0.000154	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—AKT1—atherosclerosis	4.82e-06	0.000143	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—AKT1—atherosclerosis	2.85e-06	8.42e-05	CbGpPWpGaD
